Palivizumab prophylaxis and hospitalization for respiratory syncytial virus disease in the Stockholm infant population, 1999 through 2002.
about
Effectiveness of Palivizumab in Preventing RSV Hospitalization in High Risk Children: A Real-World PerspectiveIncidence and risk factors of hospitalization for bronchiolitis in preterm children: a retrospective longitudinal study in ItalyA prospective, open-label, non-comparative study of palivizumab prophylaxis in children at high risk of serious respiratory syncytial virus disease in the Russian Federation.Human rhinoviruses in severe respiratory disease in very low birth weight infants.Preventing hospitalizations for respiratory syncytial virus infectionPalivizumab: a review of its use in the protection of high risk infants against respiratory syncytial virus (RSV)Clara cell protein 10 polymorphism is not associated with severe respiratory syncytial virus infection.Effectiveness of palivizumab immunoprophylaxis in preterm infants against respiratory syncytial virus disease in Qatar.Prévenir les hospitalisations pour l’infection par le virus respiratoire syncytial.
P2860
Q26830864-DA5F0857-2F80-41B0-84BD-09EEA5A82A25Q33501862-9D1494F6-36E9-4237-9023-92A01196DC3CQ34401644-53A2D00C-ACA5-41CA-9E38-70D6A9C61E58Q34634685-DC27A25D-B01E-4D5D-901F-6DF1999851ADQ36082195-7A85E401-B9D2-4244-AB06-4C48246740E3Q37290618-8872B892-E022-4FED-9F2D-85159469E305Q39727645-B3596B5C-710B-4275-9F1C-035AC131C6E5Q49474232-5CAC73E8-DB4D-4120-AE5B-5713BB70013CQ53932344-9023E363-23E1-4A14-B091-226552205AFB
P2860
Palivizumab prophylaxis and hospitalization for respiratory syncytial virus disease in the Stockholm infant population, 1999 through 2002.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Palivizumab prophylaxis and ho ...... population, 1999 through 2002.
@en
Palivizumab prophylaxis and ho ...... population, 1999 through 2002.
@nl
type
label
Palivizumab prophylaxis and ho ...... population, 1999 through 2002.
@en
Palivizumab prophylaxis and ho ...... population, 1999 through 2002.
@nl
prefLabel
Palivizumab prophylaxis and ho ...... population, 1999 through 2002.
@en
Palivizumab prophylaxis and ho ...... population, 1999 through 2002.
@nl
P2093
P50
P1476
Palivizumab prophylaxis and ho ...... population, 1999 through 2002.
@en
P2093
Eva Berggren
Ewa Henckel
Hanna Kapadia
Joachim Luthander
P356
10.1097/01.INF.0000105106.93562.D3
P577
2004-01-01T00:00:00Z